Stay informed about our production, medicines and more
No one knows diabetes better than those who live it every day.
Read the story
ROSHNI
Roshni has type 1 diabetes
and lives in India
Read about our financial, social and environmental performance.
See how it all adds up
Health Canada approves RYBELSUS® (semaglutide tablets) the first and only GLP-1 analogue in a pill for the treatment of adults with type 2 diabetes April 09, 2020
Novo Nordisk Canada Inc. Response to COVID-19 – Supporting Canadians Living with Diabetes April 03, 2020
More news
People with diabetes can expect to live an active, independent life if they make a commitment to diabetes management.
Read More
Ready to be challenged? At Novo Nordisk, you will get the opportunity to build a career among talented professionals.
Join us and build a life-changing career in a global business environment.
Meet our employees
